Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007
Radiotherapy for Glioblastoma in the Elderly
NEJM 356:1527-1535, Keime-Guibert,F.,et al, 2007
Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007
Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007
MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007
Refractory Neurosarcoidosis Responsive to Infliximab
Pract Neurol 7:112-115, Kobylecki,C. &Shaunak,S., 2007
Wolff-Parkinson-White Syndrome in Patients with MELAS
Arch Neurol 64:1625-1627, Sproule,D.M.,et al, 2007
Sensorineural Hearing Loss After Radiotherapy and Chemoradiotherapy: A Single, Blinded, Randomized Study
J Clin Oncol 24:1904-1909, Low, W.K.,et al, 2006
Diffuse Pontine Glioma
UpToDate, April, Kieran,M.W., 2006
Focal Brainstem Gliomas
UpToDate, April, Kieran,M.W., 2006
Glycogen-Storage Disease Type II
eMedicine, May 2, Ibrahim,J. &McGovern,M., 2006
Infusion-Related Hypersensitivity Reactions During Natalizumab Treatment
Neurol 67:1717-1718, Phillips,J.T.,et al, 2006
Retinopathy in Survivors of Primary Central Nervous System Lymphoma
Neurol 67:2060-2062, Grimm,S.A.,et al, 2006
Acromegaly
NEJM 355:2558-2573, Melmed,S., 2006
Progressive Multifocal Leukoencephalopathy Revisited: Has the Disease Outgrown Its Name?
Ann Neurol 60:162-173, Koralnik,I.J., 2006
Onset of Creutzfeldt-Jakob Disease Mimicking an Acute Cerebrovascular Event
Neurol 67:538-539, Hohler,A.D. &Flynn,F.G., 2006
Episodic Neurologic Dysfunction with Migraine and Reversible Imaging Findings After RadiationRRH
Neurol 67:676-678, Pruitt,A.,et al, 2006
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
JAMA 295:2483-2491,2535, Aoyama,H.,et al, 2006
An 81-Year-Old Woman With Temporal Arteritis
JAMA 295:2525-2534, Shmerling,R.H., 2006
Primary Dural Lymphomas: A Clinicopathologic Study of Treatment and Outcome in Eight Patients
Neurol 66:1763-1765, Iwamoto,F.M.,et al, 2006
Emerging Monoclonal Antibody Therapies for Multiple Sclerosis
Neurologist 12:171-178, Cree,B., 2006
Natalizumab: Immune Effects and Implications for Therapy
Ann Neurol 59:731-732, Hauser,S.L. &Weiner, H.L., 2006
CT and MR Imaging Findings in Methanol Intoxication
AJNR 27:452-454, Blanco,M.,et al, 2006
Mitochondrial DNA Polymerase-y and Human Disease
Hum Mol Genet 15:R244-R252, Hudson, G.,et al, 2006
Voltage-Gated Potassium Channel Antibody-Associated Encephalitis with Basal Ganglia Lesions
Neurol 66:1780-1781, Hiraga,A., et al, 2006
Cortical Laminar Necrosis Related to Prolonged Focal Status Epilepticus
JNNP 77:104-106, Donaire,A.,et al, 2006
Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006
Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
NEJM 354:924-933,965, Yousry,T.A.,et al, 2006
Clinicopath Conf, Diffuse Large B-Cell Lymphoma, EBV-Positive, with Immunosuppression
NEJM 354:1178-1184, Case 8-2006, 2006
Cerebral Cortical Laminar Necrosis on Diffusion-Weighted MRI in Hypoglycaemic Encephalopathy
Diabet Med 22:1098-1100, Yoneda,Y. &Yamamoto,S., 2005
Efficacy of TNF a Blockade in Cyclophosphamide Resistant Neuro-Behet Disease
JNNP 76:1733-1735, Ribi,C.,et al, 2005
Clinicopath Conf., MELAS Syndrome
NEJM 353:2271-2280, Case 36-2005, 2005
Direct Decompressive Surgical Resection in the Treatment of Spinal Cord Compression Caused by Metastatic Cancer: A Randomised Trial
Lancet 366:643-648,609, Patchell,R.A.,et al, 2005
Fatal Brain Necrosis in Primary HIV Infection
Lancet 366:866, Meersseman,W.,et al, 2005
Long-Term Efficacy of Early Versus Delayed Radiotherapy for Low-Grade Astrocytoma and Oligodendroglioma in Adults:The EORTC 22845 Randomised Trial
Lancet 366:985-990, van den Bent,M.J.,et al, 2005
Clinical Outcome in Patients with High-Grade Internal Carotid Artery Stenosis After Irradiation
Neurol 65:959-961, Marcel,M.,et al, 2005
MR Imaging of Nonalcoholic Wernicke Encephalopathy: A Follow-Up Study
AJNR 26:2301-2305, Zhong,C.,et al, 2005
Delayed Neurotoxicity in Primary Central Nervous System Lymphoma
Arch Neurol 62:1595-1600, Omuro,A.M.P.,et al, 2005
Infliximab and Reactivation of Cerebral Toxoplasmosis
NEJM 353:1530-1531, Callegari,P.E., 2005
Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Imaging in Creutzfeldt-Jakob Disease:High Sensitivity and Specificity for Diagnosis
AJNR 26:1551-1562, Young,G.S.,et al, 2005
Diffusion-Weighted Imaging of Radiation-Induced Brain Injury for Differentiation from Tumor Recurrence
AJNR 26:1455-1460,1305, Asao,C.,et al, 2005
Intracranial meningioma and ionizing radiation in medical and occupational settings
Neurol 64:350-352, Phillips, L.E., et al, 2005
Diffusion Abnormality of Deep Gray Matter in External Capsular Hemorrhage
AJNR 26:229-235, Moon, W-J., et al, 2005
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
NEJM 352:987-996, 1036, Stupp,R., et al, 2005
Intravascular Lymphoma: Magnetic Resonance Imaging Correlates of Disease Dynamics Within the Central Nervous System
JNNP 76:540-544, Baehring,J.M.,et al, 2005
Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005
Neuropathy Resembling CIDP in Patients Receiving Tumor Necrosis Factor-a Blockers
Neurol 64:1468-1470, Richez,C.,et al, 2005
Radiation-Induced Cavernomas of the Brain
AJNR 26:1158-1162, Jain,R.,et al, 2005
NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report
Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005